Archive for the ‘health’ tag: Page 17
Dec 15, 2017
Bioquark Inc. — Health Professional Radio
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, business, cryonics, DNA, genetics, health, life extension, science, transhumanism
Dec 15, 2017
Bioquark Inc. — The Inner Game Of Aging Podcast
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, cryonics, DNA, genetics, health, life extension, science, transhumanism
Dec 15, 2017
Bioquark Inc. — Happy and Healthy Over 40 Podcast
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, cryonics, disruptive technology, health, life extension, posthumanism, transhumanism
Dec 2, 2017
Dr. Steven Gundry says plant-based diets are the problem
Posted by Philip Raymond in categories: biotech/medical, evolution, food, life extension
Have you seen the clickbait campaign that focuses on the research of Dr. Steven Gundry. It employs a slimy, photo-tile lure that asks you to turn up your speakers and then hawks a product or service disguised as a breakthrough discovery. These scams force the viewer to stay on the page. Typically, there is no indication of how long the video is, or any way to skip forward,
But often, it is hard to tell if a photo tile is news or clickbait. Big companies like Yahoo and Outbrain intermingle genuine news with marketing scams, teasers and outright fake news into an array of little photos at the end of every feature. This particular clickbait may be a story of a dogged counter-cultural researcher with a genuinely relevant finding. It could be newsworthy…I’m just not sure. Dr. Gundry clearly believes that our health is adversely affected by many of the plant based foods that we thought was healthy, because of a defense mechanism linked to lectin.
Steven Gundry Food Pyramid
Passing judgement on Dr. Gundry’s evolutionary claims and diet recommendations begs for independent clinical studies, or at least the analysis and commentary of scholars in nutrition, gastroenterology and evolution. But, like Robert Atkins and Dean Ornish, Dr. Gundry seems earnest in his research and motives. I don’t think that he is selling anything other than his opinion.
Continue reading “Dr. Steven Gundry says plant-based diets are the problem” »
Jul 5, 2017
Revita Life Sciences Continues to Advance Multi-Modality Protocol in Attempt to Revive Brain Dead Subjects
Posted by Ira S. Pastor in categories: bioengineering, biotech/medical, cryonics, futurism, genetics, health, life extension, neuroscience, posthumanism
Rudrapur, Uttrakhand, India — July 02, 2017
Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational regenerative therapeutic applications, has announced that it is continuing to advance their novel, multi-modality clinical intervention in the state of brain death in humans.
“We have proactively continued to advance our multi-modality protocol, as an extended treatment before extubation, in an attempt to reverse the state of brain death” said Mr.Pranjal Agrawal, CEO Revita Life Sciences. “This treatment approach has yielded some very encouraging initial outcome signs, ranging from minor observations on blood pressure changes with response to painful stimuli, to eye opening and finger movements, with corresponding transient to permanent reversal changes in EEG patterns.”
Jun 29, 2017
Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, disruptive technology, DNA, genetics, health, life extension, posthumanism, science
Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.
“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”
Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.
Jun 22, 2017
Are Artificial Wombs the Future of Birth?
Posted by Johnny Boston in categories: biological, biotech/medical, ethics, evolution, futurism, health, science, sex, transhumanism
In April, Scientists based in Philadelphia unveiled an artificial womb undergoing testing on fetal lambs. With a prediction from one of the researchers that the technology could be ready for human testing in three to five years, artificial wombs suddenly became the most unexpected rage of 2017. But what sort of artificial wombs might realistically be a part of healthcare in the near future?
In this video series, the Galactic Public Archives takes bite-sized looks at a variety of terms, technologies, and ideas that are likely to be prominent in the future. Terms are regularly changing and being redefined with the passing of time. With constant breakthroughs and the development of new technology and other resources, we seek to define what these things are and how they will impact our future.
Feb 22, 2017
Bioquark Inc. and SC21 Biotech to Collaborate on Novel Cellular Therapies for Long Term HIV Control
Posted by Ira S. Pastor in categories: bioengineering, biotech/medical, business, disruptive technology, DNA, genetics, health, science, sex
Orginal press: http://www.prweb.com/releases/2017/02/prweb14062199.htm
Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel biologics for complex regeneration and disease reversion, and SC21 Biotech, (http://www.sc21bio.tech), a biotechnology company focused on translational therapeutic applications of autologous stem cell therapy, have announced a collaboration to focus on novel cellular reprogramming and production approaches for CCR5 Delta32 homozygous cord blood stem cells, for long-term control of HIV via transplantation.
“We are very excited about this collaboration with SC21 Biotech,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular reprogramming tools and SC21 Biotech’s translational cell therapy experience, will make for a transformational opportunity in this area of HIV disease control.”
Jan 5, 2017
Bioquark Inc. Announces Approval of Bioquantine Food Ingredients in Eurasian Customs Union
Posted by Ira S. Pastor in categories: aging, biotech/medical, business, disruptive technology, food, genetics, health, life extension, science, transhumanism
Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, announced the commercial approval of naturally derived Bioquantine food ingredients in the Eurasian Customs Union (formerly known as the Customs Union of Belarus, Kazakhstan, and Russia). Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, collaborated with Bioquark Inc. on the regulatory approvals.
“We are very excited about this successful regulatory approval,” said Ira S. Pastor, CEO, Bioquark Inc. “The commercialization of Bioquantine food ingredients, including functional foods, drinks, and dietary supplements, represents another important step in our continued evolution as a company focused on a broad range of products and services in the regenerative healthcare space.”
Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.
